Raloxifene does not affect insulin sensitivity or glycemic control in postmenopausal women with type 2 diabetes mellitus: a randomized clinical trial - Andersson, B; Johannsson, G; Holm, G (J Clin Endocrinol Metab, 2002)
et al.